Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence

Journal of Feline Medicine and Surgery

Volumn 13, Issue 12, 2011, Pages 927-933

  Beatty, Julia A ^a   Tasker, Séverine ^b   Jarrett, Oswald ^c   Lam, Amy ^a   Gibson, Stephanie ^a   Noe Nordberg, Alice ^d   Phillips, Angela ^e   Fawcett, Anne ^e   Barrs, Vanessa R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d Concord Animal Hospital ^*  (Australia)

^e Sydney Animal Hospitals Inner West   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FELIDAE; ONCOVIRINAE;

BIOLOGICAL MARKER; VIRUS DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; EPIDEMIOLOGY; FELINE LEUKEMIA; FELINE LEUKEMIA VIRUS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; REAL TIME POLYMERASE CHAIN REACTION; UNITED KINGDOM;

ANIMALS; BIOLOGICAL MARKERS; CATS; DNA, VIRAL; ENGLAND; FEMALE; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES;

EID: 84857965015     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2011.07.011     Document Type: Article

References (45)

1. Jarrett WF, Martin WB, Crighton GW, Dalton RG, Stewart MF. Transmission experiments with leukemia (lymphosarcoma). Nature 1964; 202: 566-7.
2. Pedersen NC, Theilen G, Keane MA, et al. Studies of naturally transmitted feline leukemia virus infection. Am J Vet Res 1977; 38: 1523-31.
3. Rojko JL, Hardy WD. Feline leukemia virus and other retroviruses. In: Sherding RG, ed. The cat: diseases and clinical management. Philadelphia: WB Saunders, 1994: 263-432.
4. Hardy WD, Hess PW, MacEwen EG, et al. Biology of feline leukemia virus in the natural environment. Cancer Res 1976; 36: 582-8.
5. McClelland AJ, Hardy WD, Zuckerman EE. Prognosis of healthy feline leukemia virus infected cats. In: Hardy WD, Essex M, McClelland AJ, eds. Developments in Cancer Research 1980; Vol 4: North Holland: Elsevier, 1980: 121-6.
6. Hardy WD. Immunopathology induced by the feline leukemia virus. Springer Semin Immunopathol 1982; 5: 75-106.
7. Reinacher M. Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats. Vet Immunol Immunopathol 1989; 21: 85e95.
8. Louwerens M, London CA, Pedersen NC, Lyons LA. Feline lymphoma in the post-feline leukemia virus era. J Vet Intern Med 2005; 19: 329-35.
9. Gleich SE, Krieger S, Hartmann K. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. J Feline Med Surg 2009; 11: 985-92.
10. Hofmann-Lehmann R, Huder JB, Gruber S, Boretti F, Sigrist B, Lutz H. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol 2001; 82: 1589-96.
11. Hofmann-Lehmann R, Tandon R, Boretti FS, et al. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 2006; 24: 1087-94.
12. Hofmann-Lehmann R, Cattori V, Tandon R, et al. Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up. Vaccine 2007; 25: 5531-9.
13. Tandon R, Cattori V, Gomes-Keller MA, et al. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction. J Virol Methods 2005; 130: 124-32.
14. Torres AN, Mathiason CK, Hoover EA. Re-examination of feline leukemia virus: host relationships using real-time PCR. Virology 2005; 332: 272-83.
15. Torres AN, O'Halloran KP, Larson LJ, Schultz RD, Hoover EA. Feline leukemia virus immunity induced by whole inactivated virus vaccination. Vet Immunol Immunopathol 2010; 134: 122-31.
16. Pinches MD, Helps CR, Gruffydd-Jones TJ, Egan K, Jarrett O, Tasker S. Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J Feline Med Surg 2007; 9: 8-13.
17. Gomes-Keller MA, Gönczi E, Tandon R, et al. Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J Clin Microbiol 2006; 44: 916-22.
18. Arjona A, Barquero N, Doménech A, et al. Evaluation of a novel nested PCR for the routine diagnosis of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). J Feline Med Surg 2007; 9: 14-22.
19. Madewell BR, Jarrett O. Recovery of feline leukaemia virus from non-viraemic cats. Vet Rec 1983; 112: 339-42.
20. Francis DP, Essex M, Jakowski RM, Cotter SM, Lerer TJ, Hardy WD. Increased risk for lymphoma and glomerulonephritis in a closed population of cats exposed to feline leukemia virus. Am J Epidemiol 1980; 111: 337-46.
21. Onions D. Animal models: lessons from feline and bovine leukaemia virus infections. Leuk Res 1985; 9: 709-11.
22. Jackson ML, Haines DM, Meric SM, Misra V. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Can J Vet Res 1993; 57: 269-76.
23. Gabor LJ, Jackson ML, Trask B, Malik R, Canfield PJ. Feline leukaemia virus status of Australian cats with lymphosarcoma. Aust Vet J 2001a; 79: 476-81.
24. Herring ES, Troy GC, Toth TE, Forrester SD, Weigt LA, Herring IP. Detection of feline leukaemia virus in blood and bone marrow of cats with varying suspicion of latent infection. J Feline Med Surg 2001; 3: 133-41.
25. Wang J, Kyaw-Tanner M, Lee C, Robinson WF. Characterisation of lymphosarcomas in Australian cats using polymerase chain reaction and immunohistochemical examination. Aust Vet J 2001; 79: 41-6.
26. Stützer B, Müller F, Majzoub M, et al. Role of latent feline leukemia virus infection in nonregenerative cytopenias of cats. J Vet Intern Med 2010; 24: 192-7.
27. Suntz M, Failing K, Hecht W, Schwartz D, Reinacher M. High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings. Vet Immunol Immunopathol 2010; 136: 71-80.
28. Stützer B, Lutz H, Majzoub M, et al. Incidence of persistent viraemia and latent feline leukemia virus infection in cats with lymphoma. J Feline Med Surg 2011; 13: 81-7.
29. Malik R, Kendall K, Cridland J, et al. Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust Vet J 1997; 75: 323-7.
30. Hartmann K, Griessmayr P, Schulz B, et al. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection. J Feline Med Surg 2007; 9: 439-45.
31. Hofmann-Lehmann R, Holznagel E, Ossent P, Lutz H. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol 1997; 4: 33-42.
32. Goldkamp CE, Levy JK, Edinboro CH, Lachtara JL. Seroprevalences of feline leukemia virus and feline immunodeficiency virus in cats with abscesses or bite wounds and rate of veterinarian compliance with current guidelines for retrovirus testing. J Am Vet Med Assoc 2008; 232: 1152-8.
33. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus
34. Report of the National FeLV/FIV Awareness Project
35. Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential
36. Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection
37. Feline leukemia virus: pathogenesis of neoplastic disease
38. Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia
39. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968e1988)
40. Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumorigenesis
41. Retrospective study of 60 cases of feline lymphosarcoma
42. Feline immunodeficiency virus status of Australian cats with lymphosarcoma
43. No evidence of vertical transmission of naturally acquired feline immunodeficiency virus infection
44. Modelling the feline leukemia virus (FeLV) in natural populations of cats (Felis catus)